March 25, 2020 / 9:29 PM / 15 days ago

BRIEF-Opiant Pharmaceuticals To Delay Recruitment For Phase 2 Study For Opnt002 Due To Covid-19

March 25 (Reuters) - Opiant Pharmaceuticals Inc:

* OPIANT PHARMACEUTICALS INC - DECIDED TO DELAY STARTING RECRUITMENT FOR PHASE 2 STUDY FOR OPNT002 DUE TO COVID-19

* OPIANT PHARMACEUTICALS INC - COVID-19 HAS NOT IMPACTED OUR ONGOING DEVELOPMENT PROGRAMS FOR OPNT003 AND OPNT004 Source :(bit.ly/2UiiM99) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below